Vanderbilt University Medical Center: New Study Examines Alzheimer's Disease Images and Molecular Biomarkers
May 08, 2020
May 08, 2020
NASHVILLE, Tennessee, May 8 -- Vanderbilt University Medical Center issued the following news:
Alzheimer's disease (AD) involves distinctive wasting away of certain brain regions, such that medical imaging of these regions can distinguish the disease from other subtypes of dementia.
A new study examines associations between various brain pathology biomarkers (measured in cerebrospinal fluid) and two magnetic resonance imaging (MRI) signatures of AD gray matter atrophy, . . .
Alzheimer's disease (AD) involves distinctive wasting away of certain brain regions, such that medical imaging of these regions can distinguish the disease from other subtypes of dementia.
A new study examines associations between various brain pathology biomarkers (measured in cerebrospinal fluid) and two magnetic resonance imaging (MRI) signatures of AD gray matter atrophy, . . .